News Quantified

OCGN – ocugen, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN

Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress [Yahoo! Finance]

Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress

-5.0%

BEAT

-10.4%

MISS

-3.4%

BEAT

Chardan Capital

Form EFFECT Ocugen, Inc.

Form 10-K/A Ocugen, Inc. For: Dec 31

Form 8-K Ocugen, Inc. For: Apr 26

Form S-3 Ocugen, Inc.

Form S-8 Ocugen, Inc.

Top News Gainers

10/9 Ocugen Announces Share Repurchase Program 32.3%

1/3 Form 8-K Ocugen, Inc. For: Jan 01 31.4%

11/26 Form 8-K Ocugen, Inc. For: Nov 21 19.4%

12/13 Form 3 Ocugen, Inc. For: Sep 27 Filed by: Musunuri Shankar 13.8%

4/7 Ocugen Appoints Kirsten Castillo and Prabhavathi Fernandes to Board of Directors 12.6%

2/10 Ocugen to Present at NobleCon16 - Noble Capital Markets’ Sixteenth Annual Investor Conference 9.7%

5/1 Form 8-K Ocugen, Inc. For: Apr 30 8.0%

11/20 Form 4 Ocugen, Inc. For: Nov 18 Filed by: Zhang Junge 6.5%

10/15 Form 4 Ocugen, Inc. For: Oct 11 Filed by: Zhang Junge 6.3%

12/5 Form 4 Ocugen, Inc. For: Dec 04 Filed by: Zhang Junge 6.1%

Top News Decliners

9/30 Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics -59.3%

10/7 Form 8-K Ocugen, Inc. For: Oct 04 -33.7%

3/27 Ocugen Provides Business Update and Full Year 2019 Financial Results -23.1%

11/8 Ocugen Provides Business Update and Third Quarter 2019 Financial Highlights -21.3%

10/2 Form SC 13D/A Ocugen, Inc. Filed by: Wilmslow Estates Ltd -19.4%

11/12 Form 10-Q Ocugen, Inc. For: Sep 30 -18.1%

4/22 Form 8-K Ocugen, Inc. For: Apr 22 -15.0%

12/30 Ocugen (NASDAQ: OCGN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -14.8%

11/8 Form DEF 14A Ocugen, Inc. For: Dec 18 -14.6%

10/9 Form 8-K Ocugen, Inc. For: Oct 08 -13.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day